Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
Hereditary transthyretin-mediated amyloidosis is a rapidly progressive, heterogeneous disease caused by the accumulation of misfolded transthyretin protein as amyloid fibrils at multiple sites, and is characterized by peripheral sensorimotor neuropathy, autonomic neuropathy and/or cardiomyopathy. Cu...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 Nov 2018
|
| In: |
Neurodegenerative disease management
Year: 2018, Jahrgang: 9, Heft: 1, Pages: 5-23 |
| ISSN: | 1758-2024 |
| DOI: | 10.2217/nmt-2018-0033 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.2217/nmt-2018-0033 Verlag: https://www.futuremedicine.com/doi/10.2217/nmt-2018-0033 
|
| Verfasserangaben: | Arnt V. Kristen, Senda Ajroud-Driss, Isabel Conceição, Peter Gorevic, Theodoros Kyriakides, & Laura Obici |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1680689460 | ||
| 003 | DE-627 | ||
| 005 | 20230427033302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191030s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/nmt-2018-0033 |2 doi | |
| 035 | |a (DE-627)1680689460 | ||
| 035 | |a (DE-599)KXP1680689460 | ||
| 035 | |a (OCoLC)1341249559 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kristen, Arnt |d 1974- |e VerfasserIn |0 (DE-588)123480965 |0 (DE-627)706314530 |0 (DE-576)293726876 |4 aut | |
| 245 | 1 | 0 | |a Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis |c Arnt V. Kristen, Senda Ajroud-Driss, Isabel Conceição, Peter Gorevic, Theodoros Kyriakides, & Laura Obici |
| 264 | 1 | |c 27 Nov 2018 | |
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.10.2019 | ||
| 520 | |a Hereditary transthyretin-mediated amyloidosis is a rapidly progressive, heterogeneous disease caused by the accumulation of misfolded transthyretin protein as amyloid fibrils at multiple sites, and is characterized by peripheral sensorimotor neuropathy, autonomic neuropathy and/or cardiomyopathy. Current treatment options have limited efficacy and often do not prevent disease progression. Patisiran is a novel RNA interference therapeutic that specifically reduces production of both wild-type and mutant transthyretin protein. In Phase II, III and long-term extension studies in patients with hereditary transthyretin-mediated amyloidosis, patisiran has consistently slowed or improved progression of neuropathy. In addition, the Phase III trial demonstrated significant improvements in quality of life measures and indicators of cardiomyopathy. Here, we highlight efficacy and safety data from the patisiran clinical trial programme. | ||
| 700 | 1 | |a Ajroud-Driss, Senda |e VerfasserIn |4 aut | |
| 700 | 1 | |a Conceição, Isabel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gorevic, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kyriakides, Theodoros |e VerfasserIn |4 aut | |
| 700 | 1 | |a Obici, Laura |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurodegenerative disease management |d London : Future Medicine, 2011 |g 9(2018), 1, Seite 5-23 |w (DE-627)767564820 |w (DE-600)2732090-X |w (DE-576)39343687X |x 1758-2024 |7 nnas |a Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis |
| 773 | 1 | 8 | |g volume:9 |g year:2018 |g number:1 |g pages:5-23 |g extent:19 |a Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis |
| 856 | 4 | 0 | |u https://doi.org/10.2217/nmt-2018-0033 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.futuremedicine.com/doi/10.2217/nmt-2018-0033 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191030 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 123480965 |a Kristen, Arnt |m 123480965:Kristen, Arnt |d 910000 |d 910100 |e 910000PK123480965 |e 910100PK123480965 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1680689460 |e 3531133934 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1680689460","note":["Gesehen am 30.10.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis","title":"Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis"}],"relHost":[{"title":[{"title_sort":"Neurodegenerative disease management","title":"Neurodegenerative disease management"}],"origin":[{"publisherPlace":"London","dateIssuedKey":"2011","publisher":"Future Medicine","dateIssuedDisp":"2011-"}],"id":{"issn":["1758-2024"],"zdb":["2732090-X"],"eki":["767564820"]},"language":["eng"],"disp":"Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosisNeurodegenerative disease management","part":{"extent":"19","year":"2018","pages":"5-23","text":"9(2018), 1, Seite 5-23","issue":"1","volume":"9"},"recId":"767564820","pubHistory":["1.2011 -"],"type":{"bibl":"periodical"}}],"name":{"displayForm":["Arnt V. Kristen, Senda Ajroud-Driss, Isabel Conceição, Peter Gorevic, Theodoros Kyriakides, & Laura Obici"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"27 Nov 2018"}],"id":{"eki":["1680689460"],"doi":["10.2217/nmt-2018-0033"]},"physDesc":[{"extent":"19 S."}],"language":["eng"],"person":[{"family":"Kristen","display":"Kristen, Arnt","role":"aut","roleDisplay":"VerfasserIn","given":"Arnt"},{"display":"Ajroud-Driss, Senda","role":"aut","roleDisplay":"VerfasserIn","given":"Senda","family":"Ajroud-Driss"},{"given":"Isabel","roleDisplay":"VerfasserIn","role":"aut","display":"Conceição, Isabel","family":"Conceição"},{"family":"Gorevic","given":"Peter","roleDisplay":"VerfasserIn","role":"aut","display":"Gorevic, Peter"},{"family":"Kyriakides","role":"aut","roleDisplay":"VerfasserIn","given":"Theodoros","display":"Kyriakides, Theodoros"},{"family":"Obici","roleDisplay":"VerfasserIn","role":"aut","given":"Laura","display":"Obici, Laura"}]} | ||
| SRT | |a KRISTENARNPATISIRANA2720 | ||